⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16875685 | 0.72 | CA12 (0.32) | — | |
| SCHEMBL23781544 | 0.70 | CPT2 (0.34) | — | |
| SCHEMBL2570752 | 0.70 | — | — | |
| SCHEMBL16875690 | 0.70 | — | — | |
| SCHEMBL57128 | 0.62 | PARL (0.38) | — | |
| SCHEMBL1350795 | 0.62 | PARL (0.31) | — | |
| SCHEMBL1350799 | 0.62 | PARL (0.31) | — | |
| SCHEMBL230241 | 0.61 | PARL (0.34) | — | |
| SCHEMBL379296 | 0.61 | PARL (0.34) | — | |
| SCHEMBL16875684 | 0.61 | MGLL (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 490 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2971064-B1 | PROXIMITY ASSAY FOR IN SITU DETECTION OF TARGETS | VENTANA MED SYST INC (US) | 2019-10-16 | — | — | EP | claimed |
| US-9663814-B2 | Proximity assay for in situ detection of targets | VENTANA MEDICAL SYSTEMS, INC. (US) | 2017-05-30 | — | — | US | claimed |
| EP-1853634-B1 | ACTIVATED SIALIC ACID DERIVATIVES FOR PROTEIN DERIVATISATION AND CONJUGATION | LIPOXEN TECHNOLOGIES LTD (GB) | 2016-08-10 | — | — | EP | claimed |
| EP-2971064-A1 | PROXIMITY ASSAY FOR IN SITU DETECTION OF TARGETS | Ventana Medical Systems, Inc. (US) | 2016-01-20 | — | — | EP | claimed |
| US-20160002701-A1 | Proximity Assay for In Situ Detection of Targets | VENTANA MEDICAL SYSTEMS, INC. | 2016-01-07 | — | — | US | claimed |
| WO-2014139980-A1 | PROXIMITY ASSAY FOR IN SITU DETECTION OF TARGETS | VENTANA MEDICAL SYSTEMS, INC. (US) | 2014-09-18 | — | — | WO | claimed |
| WO-2014139979-A1 | QUANTUM DOT IN SITU HYBRIDIZATION | VENTANA MEDICAL SYSTEMS, INC. (US) | 2014-09-18 | — | — | WO | claimed |
| EP-2276499-B1 | RECOMBINANT DEAMIDATED GLIADIN ANTIGEN | BIO RAD LABORATORIES (US) | 2013-06-12 | — | — | EP | claimed |
| US-5427929-A | Enzyme pretreatment | AMGEN INC. (US) | 1995-06-27 | — | — | US | claimed |
| WO-1988008875-A1 | CYCLING BIOCHIP SENSOR | THE WASHINGTON TECHNOLOGY CENTER (US) | 1988-11-17 | — | — | WO | claimed |
| EP-4743220-A1 | DRIED REAGENTS | Olink Proteomics AB (SE) | 2026-05-20 | — | — | EP | disclosed |
| EP-4743076-A2 | SYNTHETIC BI-FUNCTIONAL DEGRADERS OF INTEGRINS | The Board of Trustees of the Leland Stanford Junior University (US) | 2026-05-20 | — | — | EP | disclosed |
| EP-3600372-B1 | SYNTHEKINE COMPOSITIONS AND METHODS OF USE | UNIV LELAND STANFORD JUNIOR (US) | 2026-05-13 | — | — | EP | disclosed |
| US-12601683-B2 | Serial multichannel microscopy | Miltenyi Biotec B.V. & Co. KG (DE) | 2026-04-14 | — | — | US | disclosed |
| EP-4441079-B1 | SWITCHABLE POLYPEPTIDE AND ITS USE FOR GENTLE AFFINITY PURIFICATION | UNIV OXFORD INNOVATION LTD (GB) | 2026-02-11 | — | — | EP | disclosed |
| EP-0481069-A1 | METHOD FOR REDUCING CARRYOVER CONTAMINATION IN AN AMPLIFICATION PROCEDURE | AMGEN INC. (US) | 1992-04-22 | — | — | EP | disclosed |
| US-5094950-A | Diagnostics | NIHON MEDI-PHYSICS CO., LTD. (JP) | 1992-03-10 | — | — | US | disclosed |
| WO-1991017270-A1 | METHOD FOR REDUCING CARRYOVER CONTAMINATION IN AN AMPLIFICATION PROCEDURE | AMGEN INC. (US) | 1991-11-14 | — | — | WO | disclosed |
| EP-0345723-A2 | Diethylenetriamine pentaacetic acid derivatives | NIHON MEDI-PHYSICS CO., LTD. (JP) | 1989-12-13 | — | — | EP | disclosed |
| WO-1988008875-A1 | CYCLING BIOCHIP SENSOR | THE WASHINGTON TECHNOLOGY CENTER (US) | 1988-11-17 | — | — | WO | disclosed |